Neogen Corporation (NEOG)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Neogen Corporation currently loses $5.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 8
in 28 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Next report — what to expect
Neogen Corporation (NEOG) reports on October 8, 2026. Wall Street is looking for EPS of $0.05 on revenue of $207.9 million. For trailing context, revenue declined -0.1% year over year last quarter. NEOG has beaten EPS in 4 of 8 most recent quarters, so attention may center on any update versus those expectations.
About Neogen Corporation
Neogen Corporation (NASDAQ: NEOG) develops and sells diagnostics and related animal-health products for the healthcare field, with operations centered on food and animal safety. The company generated $870.4 million of revenue in FY2026. Its business spans contaminant detection, sanitation verification, veterinary care, and hygiene products sold into testing and production environments worldwide.
Today's Snapshot
NEOG closed slightly higher at 11.92.
Trading Volume
Above 10d avg 2.2M
6M
vs S&P 500 Today
Outperforming Market
+0.77%
Updated: September 10, 2026 at 12:29 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$9.27 - $11.77Buy
- RSI (14)59.73Neutral
- Stochastic %K (14, 3, 3)53.26Neutral
- MACD Level (12, 26)0.25Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.